Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
An Observational Study of the Impact of Systemic B-cell Depletion on Cervicovaginal Mucosal Environment.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
Anti-PLA2R antibody levels are associated with thromboembolism risk in individuals with membranous nephropathy and hypoalbuminemia.
Journal: Journal of nephrology
Published: January 17, 2026
Long-term B-cell depletion with rituximab in relapsing, refractory and severe lupus nephritis: a retrospective case series.
Journal: Clinical kidney journal
Published: August 29, 2025
Should Nephrology Clinical Trials Account for Apolipoprotein L1 Gene Risk Status?
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: August 04, 2025
How I Treat Challenging Cases of Antibody-Mediated Glomerular Diseases.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: July 29, 2025
Protracted COVID-19 pneumonia in B-cell-depleted patients.
Journal: Rheumatology (Oxford, England)
Published: December 16, 2024
Persistent B Cell Depletion After Rituximab for Autoimmune and Glomerular Diseases: A Case Series.
Journal: Kidney international reports
Published: November 01, 2024
Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis.
Journal: Kidney international reports
Published: September 16, 2024
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.
Journal: Science translational medicine
Published: November 29, 2023
Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Journal: Kidney international reports
Published: October 28, 2023
Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan.
Journal: RMD open
Published: June 26, 2023
Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial.
Journal: Annals of the rheumatic diseases
Published: May 25, 2023
Last Updated: 09/26/2026